Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Reference32 articles.
1. Epstein M, McGrath S, Law F (2006) Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 355:1834–1836
2. William JH, Danziger J (2016) Magnesium deficiency and proton-pump inhibitor use: a clinical review. J Clin Pharmacol 56:660–668
3. Sivakumar J (2016) Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review. Int J Physiol Pathophysiol Pharmacol 8:169–174
4. Center for Drug Evaluation, Research (2019) Low magnesium levels can be associated with long-term use of PPIs. In: U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-low-magnesium-levels-can-be-associated-long-term-use-proton-pump. Accessed 30 Oct 2019
5. Liao S, Gan L, Mei Z (2019) Does the use of proton pump inhibitors increase the risk of hypomagnesemia: an updated systematic review and meta-analysis. Medicine 98:e15011. https://doi.org/10.1097/MD.0000000000015011
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献